Stephen Neil Gomperts, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lewy Body Disease | 17 | 2024 | 252 | 6.190 |
Why?
|
Parkinson Disease | 17 | 2024 | 2877 | 2.550 |
Why?
|
Amyloid beta-Peptides | 11 | 2024 | 3839 | 1.850 |
Why?
|
Hippocampus | 10 | 2024 | 3766 | 1.490 |
Why?
|
Carbolines | 8 | 2021 | 296 | 1.340 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 3 | 2021 | 415 | 1.290 |
Why?
|
Positron-Emission Tomography | 15 | 2024 | 6484 | 1.070 |
Why?
|
tau Proteins | 6 | 2024 | 2095 | 0.960 |
Why?
|
Alzheimer Disease | 15 | 2024 | 8601 | 0.880 |
Why?
|
Putamen | 2 | 2021 | 292 | 0.800 |
Why?
|
Basal Ganglia Diseases | 1 | 2021 | 145 | 0.710 |
Why?
|
Nicotine | 1 | 2024 | 680 | 0.630 |
Why?
|
Neurofilament Proteins | 1 | 2021 | 336 | 0.620 |
Why?
|
Second Messenger Systems | 1 | 2019 | 202 | 0.610 |
Why?
|
Dementia | 5 | 2023 | 2689 | 0.520 |
Why?
|
Aniline Compounds | 7 | 2019 | 1069 | 0.510 |
Why?
|
Brain | 12 | 2024 | 27121 | 0.490 |
Why?
|
Ventral Tegmental Area | 1 | 2015 | 136 | 0.460 |
Why?
|
Thiazoles | 7 | 2019 | 1517 | 0.440 |
Why?
|
Calcium | 6 | 2024 | 5722 | 0.420 |
Why?
|
Neocortex | 1 | 2016 | 417 | 0.420 |
Why?
|
Wakefulness | 1 | 2019 | 1265 | 0.390 |
Why?
|
Neural Pathways | 2 | 2021 | 3060 | 0.360 |
Why?
|
Sleep | 4 | 2024 | 4768 | 0.350 |
Why?
|
Amyloid | 3 | 2019 | 841 | 0.340 |
Why?
|
Neurons | 7 | 2024 | 9463 | 0.310 |
Why?
|
Cerebral Cortex | 3 | 2024 | 5779 | 0.300 |
Why?
|
Neuropsychological Tests | 7 | 2024 | 7054 | 0.300 |
Why?
|
Disease Progression | 4 | 2023 | 13510 | 0.280 |
Why?
|
Cognition | 4 | 2024 | 6992 | 0.280 |
Why?
|
Smoking | 1 | 2024 | 9053 | 0.280 |
Why?
|
Mice, Transgenic | 6 | 2024 | 9542 | 0.270 |
Why?
|
Radiopharmaceuticals | 5 | 2024 | 2650 | 0.250 |
Why?
|
Disease Management | 1 | 2016 | 2508 | 0.250 |
Why?
|
Dementia, Vascular | 1 | 2024 | 122 | 0.220 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2024 | 140 | 0.220 |
Why?
|
Receptors, AMPA | 3 | 2000 | 336 | 0.210 |
Why?
|
Tauopathies | 2 | 2017 | 320 | 0.200 |
Why?
|
Cocaine | 2 | 2019 | 958 | 0.200 |
Why?
|
Aged | 19 | 2024 | 169310 | 0.200 |
Why?
|
Action Potentials | 3 | 2024 | 1834 | 0.190 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 26129 | 0.190 |
Why?
|
Astrocytes | 3 | 2024 | 1346 | 0.190 |
Why?
|
Synapses | 3 | 2000 | 1769 | 0.190 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 4 | 2000 | 895 | 0.190 |
Why?
|
Supranuclear Palsy, Progressive | 2 | 2017 | 81 | 0.180 |
Why?
|
Disease Models, Animal | 6 | 2024 | 18255 | 0.170 |
Why?
|
Glucosylceramidase | 1 | 2020 | 127 | 0.170 |
Why?
|
Aged, 80 and over | 8 | 2024 | 58984 | 0.160 |
Why?
|
Receptors, Glutamate | 1 | 2000 | 228 | 0.160 |
Why?
|
Middle Aged | 18 | 2024 | 220921 | 0.160 |
Why?
|
Male | 24 | 2024 | 360846 | 0.160 |
Why?
|
Autoradiography | 4 | 2024 | 728 | 0.150 |
Why?
|
Carbon Radioisotopes | 2 | 2024 | 561 | 0.150 |
Why?
|
Humans | 35 | 2024 | 761596 | 0.150 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14608 | 0.140 |
Why?
|
Female | 21 | 2024 | 392705 | 0.140 |
Why?
|
Microarray Analysis | 2 | 2009 | 750 | 0.130 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2021 | 1068 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 7 | 2024 | 36426 | 0.130 |
Why?
|
Autopsy | 1 | 2019 | 1009 | 0.130 |
Why?
|
Caffeine | 1 | 2020 | 700 | 0.120 |
Why?
|
REM Sleep Behavior Disorder | 1 | 2016 | 108 | 0.120 |
Why?
|
Neurologic Examination | 2 | 2020 | 916 | 0.110 |
Why?
|
Amyloid beta-Protein Precursor | 3 | 2024 | 1111 | 0.110 |
Why?
|
Electroencephalography | 3 | 2024 | 6237 | 0.110 |
Why?
|
Animals | 17 | 2024 | 168475 | 0.110 |
Why?
|
Congresses as Topic | 1 | 2019 | 803 | 0.110 |
Why?
|
Uric Acid | 1 | 2020 | 807 | 0.110 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2016 | 269 | 0.110 |
Why?
|
Rats | 8 | 2024 | 23741 | 0.110 |
Why?
|
Mesencephalon | 1 | 2015 | 332 | 0.110 |
Why?
|
Evoked Potentials | 1 | 1998 | 1047 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1787 | 0.100 |
Why?
|
Apolipoprotein E3 | 1 | 2012 | 107 | 0.100 |
Why?
|
Radionuclide Imaging | 1 | 2015 | 1972 | 0.100 |
Why?
|
Levodopa | 1 | 2012 | 221 | 0.100 |
Why?
|
Antiparkinson Agents | 1 | 2012 | 184 | 0.090 |
Why?
|
Cholinesterase Inhibitors | 2 | 2023 | 242 | 0.090 |
Why?
|
Mice | 9 | 2024 | 81539 | 0.090 |
Why?
|
Electrophysiology | 3 | 2009 | 1262 | 0.090 |
Why?
|
Models, Neurological | 2 | 2013 | 1769 | 0.080 |
Why?
|
Cognition Disorders | 3 | 2020 | 3980 | 0.080 |
Why?
|
Central Nervous System | 1 | 1996 | 1336 | 0.080 |
Why?
|
Cholecalciferol | 1 | 2013 | 553 | 0.080 |
Why?
|
Apolipoprotein E4 | 1 | 2012 | 709 | 0.080 |
Why?
|
Microelectrodes | 1 | 2009 | 306 | 0.070 |
Why?
|
Parietal Lobe | 1 | 2012 | 852 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 12973 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 10212 | 0.070 |
Why?
|
Contrast Media | 1 | 2019 | 5307 | 0.070 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22174 | 0.060 |
Why?
|
Tissue Distribution | 1 | 2008 | 2264 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2013 | 1388 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3429 | 0.050 |
Why?
|
Time and Motion Studies | 1 | 2023 | 143 | 0.050 |
Why?
|
Feeding Behavior | 1 | 2015 | 3188 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 1996 | 4415 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8002 | 0.050 |
Why?
|
Survival Analysis | 1 | 2015 | 10090 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase 14 | 1 | 2022 | 29 | 0.050 |
Why?
|
Synaptic Transmission | 2 | 2019 | 1173 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39106 | 0.050 |
Why?
|
Entropy | 1 | 2023 | 210 | 0.050 |
Why?
|
GTP Phosphohydrolases | 2 | 2022 | 517 | 0.050 |
Why?
|
Movement | 1 | 2008 | 1478 | 0.050 |
Why?
|
Cohort Studies | 1 | 2024 | 41495 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 4 | 2000 | 8181 | 0.050 |
Why?
|
Calcium, Dietary | 1 | 2023 | 529 | 0.040 |
Why?
|
Sleep Stages | 1 | 2024 | 694 | 0.040 |
Why?
|
Prognosis | 1 | 2021 | 29629 | 0.040 |
Why?
|
Computer Simulation | 1 | 2013 | 6241 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7391 | 0.040 |
Why?
|
Prospective Studies | 2 | 2015 | 54423 | 0.040 |
Why?
|
New Orleans | 1 | 2019 | 27 | 0.040 |
Why?
|
Sleep, REM | 1 | 2023 | 595 | 0.040 |
Why?
|
Membrane Proteins | 1 | 1996 | 7859 | 0.040 |
Why?
|
Tetrodotoxin | 1 | 2000 | 246 | 0.040 |
Why?
|
Postural Balance | 1 | 2023 | 622 | 0.040 |
Why?
|
Epilepsy | 2 | 2024 | 3290 | 0.040 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2000 | 369 | 0.040 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2000 | 195 | 0.040 |
Why?
|
Mutation | 2 | 2020 | 30053 | 0.040 |
Why?
|
Genotype | 1 | 2012 | 12990 | 0.040 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2019 | 267 | 0.040 |
Why?
|
Quinoxalines | 1 | 1998 | 296 | 0.030 |
Why?
|
Diagnosis | 1 | 2017 | 157 | 0.030 |
Why?
|
Radioligand Assay | 1 | 2017 | 366 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5672 | 0.030 |
Why?
|
Tritium | 1 | 2017 | 708 | 0.030 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 1998 | 448 | 0.030 |
Why?
|
Patch-Clamp Techniques | 1 | 1998 | 927 | 0.030 |
Why?
|
Mental Disorders | 1 | 2016 | 6845 | 0.030 |
Why?
|
TDP-43 Proteinopathies | 1 | 2015 | 38 | 0.030 |
Why?
|
Neurotransmitter Agents | 1 | 2019 | 665 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15843 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2020 | 22176 | 0.030 |
Why?
|
Plaque, Amyloid | 1 | 2019 | 760 | 0.030 |
Why?
|
Frontotemporal Lobar Degeneration | 1 | 2015 | 102 | 0.030 |
Why?
|
Microglia | 1 | 2023 | 1362 | 0.030 |
Why?
|
GTP-Binding Proteins | 1 | 1999 | 951 | 0.030 |
Why?
|
Inclusion Bodies | 1 | 2015 | 281 | 0.030 |
Why?
|
Fluorine Radioisotopes | 1 | 2017 | 418 | 0.030 |
Why?
|
ras Proteins | 1 | 1999 | 1054 | 0.030 |
Why?
|
Neuromuscular Junction | 1 | 1996 | 405 | 0.030 |
Why?
|
Potassium Channels | 1 | 1996 | 537 | 0.030 |
Why?
|
Animals, Newborn | 1 | 1998 | 2677 | 0.030 |
Why?
|
Eating | 1 | 2020 | 1539 | 0.030 |
Why?
|
Molecular Imaging | 1 | 2019 | 815 | 0.030 |
Why?
|
Brain Mapping | 2 | 2017 | 6635 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2020 | 2116 | 0.020 |
Why?
|
Atrophy | 1 | 2017 | 1633 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2019 | 9001 | 0.020 |
Why?
|
Cadaver | 1 | 2015 | 1358 | 0.020 |
Why?
|
Seizures | 1 | 2024 | 2957 | 0.020 |
Why?
|
Ion Channels | 1 | 1996 | 1040 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2735 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2015 | 822 | 0.020 |
Why?
|
Cells, Cultured | 3 | 1999 | 18966 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12341 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 1996 | 2822 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10554 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 1996 | 2872 | 0.020 |
Why?
|
rac GTP-Binding Proteins | 1 | 1999 | 162 | 0.010 |
Why?
|
rhoA GTP-Binding Protein | 1 | 1999 | 234 | 0.010 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1999 | 592 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15733 | 0.010 |
Why?
|
Cytoskeleton | 1 | 1999 | 1170 | 0.010 |
Why?
|
Adenoviridae | 1 | 1998 | 1085 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 1998 | 1206 | 0.010 |
Why?
|
Actins | 1 | 1999 | 2050 | 0.010 |
Why?
|
Cell Division | 1 | 1999 | 4465 | 0.010 |
Why?
|
Genetic Vectors | 1 | 1998 | 3396 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1998 | 6534 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2017 | 80647 | 0.000 |
Why?
|
Adult | 1 | 2017 | 221210 | 0.000 |
Why?
|
Signal Transduction | 1 | 1998 | 23447 | 0.000 |
Why?
|